Multidisciplinary Diagnosis in Action: Challenging Case Presentations

Similar documents
Case Presentations in ILD. Harold R. Collard, MD Department of Medicine University of California San Francisco

A Review of Interstitial Lung Diseases

A Review of Interstitial Lung Diseases. Paul J. Wolters, MD Associate Professor Department of Medicine University of California San Francisco

Overview of Idiopathic Pulmonary Fibrosis: Diagnosis and Therapy

INTERSTITIAL LUNG DISEASE. Radhika Reddy MD Pulmonary/Critical Care Long Beach VA Medical Center January 5, 2018

Annual Rheumatology & Therapeutics Review for Organizations & Societies

Case 1. Case Presentation. Disclosure Statement. ILD: What the generalist needs to know

4/17/2010 C ini n ca c l a Ev E a v l a ua u t a ion o n of o ILD U dat a e t e i n I LDs

Diagnosing Idiopathic Pulmonary Fibrosis on Evidence-Based Guidelines

Disclosures. Clinical Approach: Evaluating CTD-ILD for the pulmonologist. ILD in CTD. connective tissue disease or collagen vascular disease

Hypersensitivity Pneumonitis Common Diagnostic and Treatment Dilemmas

Outline Definition of Terms: Lexicon. Traction Bronchiectasis

Pathologic Assessment of Interstitial Lung Disease

IPF: Epidemiologia e stato dell arte

Update on Therapies for Idiopathic Pulmonary Fibrosis. Outline

Disclosures. Rheumatological Approaches to Differential Diagnosis, Physical Examination, and Interpretation of Studies. None

NATIONAL ASSOCIATION FOR CONTINUING EDUCATION

IPF - Inquadramento clinico

A case of a patient with IPF treated with nintedanib. Prof. Kreuter and Prof. Heussel

Myositis and Your Lungs

Lines and crackles. Making sense of ILD

INTERSTITIAL LUNG DISEASES: FOCUS ON IDIOPATHIC PULMONARY FIBROSIS (IPF)

Autoantibodies in the Idiopathic Inflammatory Myopathies

5/9/2015. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. No, I am not a pulmonologist! Radiology

NONE OVERVIEW FINANCIAL DISCLOSURES UPDATE ON IDIOPATHIC PULMONARY FIBROSIS/IPF (UIP) FOR PATHOLOGISTS. IPF = Idiopathic UIP Radiologic UIP Path UIP

Connective Tissue Disorder- Associated Interstitial Lung Disease (CTD-ILD) and Updates

CTD-related Lung Disease

Déjà vu all over again

DIAGNOSTIC NOTE TEMPLATE

Diagnostic challenges in IPF

Pharmacologic Approach to ILD

Case Study #2. Case Study #1 cont 9/28/2011. CAPA 2011 Christy Wilson PA C. LH is 78 yowf with PMHx of metz breast CA presents

Interstitial Lung Disease: Clinical Approach to Diagnosis

INTERSTITIAL LUNG DISEASE Dr. Zulqarnain Ashraf

Diffuse Interstitial Lung Diseases: Is There Really Anything New?

11/10/2014. Multi-disciplinary Approach to Diffuse Lung Disease: The Imager s Perspective. Radiology

Challenges in the Diagnosis of Interstitial Lung Disease

ILD and systemic disease

COI: no conflicts of interest to declare

Dr. Tracy Luckhardt Division of Pulmonary, Allergy and Critical Care Medicine University of Alabama at Birmingham

9/15/11. Dr. Vivien Hsu Director, UMDNJ Scleroderma Program New Brunswick, NJ September Scleroderma. Hard skin

Manish Powari Regional Training Day 10/12/2014

ERS 2016 Congress Highlights Interstitial Lung Disease (ILD)

Pulmonary Test Brenda Shinar

Triennial Pulmonary Workshop 2012

Financial disclosure COMMON DIAGNOSES IN HRCT. High Res Chest HRCT. HRCT Pre test. I have no financial relationships to disclose. Anatomy Nomenclature

Unpaid scientific collaborator & advisor with Veracyte, Inc.

Test Name Results Units Bio. Ref. Interval

Scott Vogelgesang, MD Division of Rheumatology/Immunology University of Iowa

Idiopathic Pulmonary Fibrosis Treatable and Not Idiopathic

Challenges in the Diagnosis of Interstitial Lung Disease

Undifferentiated Connective Tissue Disease and Overlap Syndromes. Mark S. Box, MD

Disclosures. Transplanting Interstitial Lung Disease. Lung Transplantation. Indications. I have nothing to disclose. Adult Lung Transplants

Disclosures. Fibrotic lung diseases: Basic Principles, Common Problems, and Reporting. Relevant financial relationships: None. Off-label usage: None

Test Name Results Units Bio. Ref. Interval

Chest Pain 101: Fine Tuning Your Differential in the Outpatient Setting. Krysten Pilkington MNSc, APRN, AG-ACNP-BC

The ABC s of ILD LIP AIP NSIP

June 2013 Pulmonary Case of the Month: Diagnosis Makes a Difference. Lewis J. Wesselius, MD 1 Henry D. Tazelaar, MD 2

Patient with IPF and no honeycombing on HRCT. Case 1 Demosthenes Bouros, Vasilios Tzilas University of Athens

Histopathologic Approach to Interstitial Lung Disease

Budsakorn Darawankul, MD. Maharat Nakhon Ratchasima Hospital

Interstitial Lung Disease (ILD)

11/19/2012. The spectrum of pulmonary diseases in HIV-infected persons is broad.

Disclosures. Traditional Paradigm. Overview 4/17/2010. I have relationships with the following organizations and companies:

Diagnosis of Connective Tissue Disease Interstitial Lung Disease in 2016

Clinical Laboratory. 14:42:00 SSA-52 (Ro52) (ENA) Antibody, IgG 1 AU/mL [0-40] Oct-18

Disclosures. IPF Medications: Practical Experience. Prednisone, Azathioprine, N acyetylcysteine. Case 1. Brett Ley, MD, MAS Assistant Professor, UCSF

Non-neoplastic Lung Disease II

APPROACH TO PATIENTS WITH POLYARTHRALGIA

High Impact Rheumatology

Challenges in Pulmonary and Critical Care 2017

Diagnosing ILD. What is important in 2016? Chris Grainge

Interstitial Lung Disease ILD: Definition

DEALING WITH A DIAGNOSIS OF PULMONARY FIBROSIS

What your autoantibodies tell us about your disease. Mark Gourley, MD

National Jewish Health. Idiopathic Pulmonary Fibrosis: A Guide for Providers

Interstitial Lung Disease in the Connective Tissue Diseases

UIP OR NOT UIP PATTERN: THAT IS NOT THE ONLY QUESTION!

Test Name Results Units Bio. Ref. Interval

ד"ר דוד ירדני המכון לגסטרואנטרולוגיה ומחלות כבד מרכז רפואי סורוקה

Liebow and Carrington's original classification of IIP

Pulmonary Function Testing The Basics of Interpretation

Progress in Idiopathic Pulmonary Fibrosis

Restrictive Pulmonary Diseases

Sleep and Neuromuscular Disease. Sharon De Cruz, MD Tisha Wang, MD

Clinical Laboratory. [None

Is it Autoimmune or NOT! Presented to AONP! October 2015!

HPI. HPI (cont.) Pause for Discussion. Clinical Problem Solving Session. CC: blurry vision

This month, we are very pleased to introduce some new tests for Scleroderma as well as some test changes to our existing scleroderma tests/panels.

Pulmonary manifestations of CTDs Diagnosis, differential diagnosis and treatment

CASE PRESENTATION VV ECMO

What do pulmonary function tests tell you?

Disclosures. Scleroderma: Early Diagnosis How early is early? 10/28/2013. Difficult Scleroderma: How do I Approach this Patient?

Timely Topics in Pulmonary Medicine

SESSION IV: MECHANISMS OF HUMAN DISEASE: LABORATORY SESSIONS PULMONARY PATHOLOGY I. December 5, 2012

IDIOPATHIC PULMONARY FIBROSIS Guidelines for Diagnosis and Management

Clinical Laboratory. 14:41:00 Complement Component 3 50 mg/dl Oct-18

SCLERODERMA. Scleroderma update. No disclosures or conflicts. Leslie Kahl, M.D. April 10, 2015

Idiopathic Pulmonary of Care

Transcription:

Multidisciplinary Diagnosis in Action: Challenging Case Presentations Interstitial Lung Disease: Advances in Diagnosis and Management UCSF CME November 8, 2014 Case 1 69 yo M 3 year history of intermittent cough and exertional dyspnea Over prior 2 years, increased functional limitation, now SOB walking across room New exertional hypoxemia ROS: Negative, no reflux symptoms or symptoms of connective tissue disease 1

69 yo M PMHx R sided primary spontaneous pneumothorax in his 20 s, pleurectomy GERD Medications Pantoprazole 20 mg daily ASA 81 mg daily Losartan 50 mg daily NKDA Environmental / Occupational History Down comforter, used in winter No birds No other mold exposures No occupational exposures Works in media and runs a non profit organization 2

Social Hx 69 Yo M Lifetime non smoker No alcohol or illicit drug abuse FHx: No known ILD Mother had PMR Physical Exam BP 120/56, HR 65, T 36.9, RR 18, Sats 96% on R/A Mild bibasilar velcro crackles R>L Otherwise unremarkable Normal cardiac exam No clubbing No signs of PH No signs of CTD 3

Physiology Oxygen saturation 97% on R/A at rest but decreased to 85% with 3 mins walking FVC FEV1 FEV1/FVC TLC DLCO March 4, 2014 3.19 L (67%) 2.72 L (77%) 74% 4.90 L (66%) 11.97 (35%) May 23, 2011 3.86 L (80%) 3.15 L (88%) 85% 5.24 L (71%) 15.48 (44%) Labs June 2011 ESR 31 mm/hr Negative Scl 70, ds DNA, C3, C4, D dimer, Jo 1, anti centromere Ab, ACE level, anti CCP Ab 4

5

6

MDD discussion Dx unclassifiable without additional information We recommended SLB Surgical Lung Biopsy 3 surgical biopsies from the left lung All lower lobe (basilar anterior x 2 and superior) Discussed during surgery 7

8

9

10

Case 1 Diagnosis Interstitial fibrosis, usual interstitial pneumonia pattern, with increased peribronchiolar fibrosis (basilar). Interstitial fibrosis, predominantly bronchiolocentric, with small non necrotizing granulomas (superior). Overlapping features that suggest chronic hypersensitivity pneumonia versus usual interstitial pneumonia. 11

Multidisciplinary Decision Based on clinical, radiologic and surgical lung biopsy, felt to be most consistent with hypersensitivity pneumonitis 12

Multidisciplinary Management Plan Remove down comforter from house HP checklist Professional home cleaning Prednisone 50 mg daily x 4 week then taper by 5 mg / week until on 20 mg and return with PFTs after 3 months of treatment Rehab, vaccines Serial PFTs Final Thoughts from the Panel 13

Case 2 77 yo M Developed dry cough that started 5 years ago Denies dyspnea, although he has "slowed down" over the last several years. Denies constitutional symptoms No reflux Denies myalgias, arthralga, sicca, Raynaud s phenomena, rash, skin changes, joint stiffness or muscle weakness 77 yo M PMHx BPH Medications Finasteride 5 mg daily Tamsulosin 0.4 mg daily NKDA 14

Environmental / Occupational History Retired factory (HVAC) and field worker Owned parakeets and cockatiels for past 2 3 years; kept outside away from home Changes the cage q 2 weeks; feeds them on alternating days. Does not handle the birds Woodworking as a hobby (builds furniture) Social Hx 77 yo M Minimal smoking history No alcohol or illicit drug use Family Hx No ILD or CTD 15

Physical Exam BP 128/69, HR 58, T 36.5, RR 20, Sats 99% R/A Bilateral inspiratory crackles at both bases No clubbing Negative rheumatologic exam No signs of pulmonary hypertension Case 2 PFTs Office walk test: Room air saturation at rest 97%, after 3 minutes walking 96% Date FVC FEV1 FEV1/FVC TLC DLCO June 24, 2014 3.70 L (117%) 2.90 L (118%) 78% 5.86 L (92%) 17.16 (62%) July 12, 2013 3.81 L (119%) 3.18 L (128%) 84% 5.61 L (88%) 19.30 (70%) 16

17

18

Surgical Lung Biopsy Two biopsies, right upper and lower lobes. 3 x 1 cm Similar wedge that is approximately 5 cm 19

20

21

Case 2 Diagnosis Interstitial fibrosis, usual interstitial pneumonia pattern. Minor component of chronic inflammation, but associated with the regions of fibrosis. 22

Initial Multidisciplinary Discussion Given clinical, radiology and surgical lung biopsy, felt the diagnosis is idiopathic pulmonary fibrosis Multidisciplinary Management Plan Remove birds Pulmonary rehab Serial PFTs Vaccines Baseline serologies 23

Labs ANA 1:640 (speckled) RF 125 SSA >150 SSB 145 Anti CCP, Scl 70, SM antibody, Sm/RNP antibody, PM Scl antibody negative Myositis panel negative EJ, Jo 1, KU, MI 2, OJ, PL 12, PL 7,SRP autoantibodies 24

Multidisciplinary Management Plan Lip biopsy to r/o Sjogren s Rheumatology consult Final Thoughts from the Panel 25

Case 3 46 yo M Developed exertional dyspnea and non productive cough in spring 2013 Progression of dyspnea over past year Cardiac work up including angiogram was negative Endorses symptoms of reflux No CTD symptoms except dry mouth Presented to ER Feb 2014 with worsening SOB, treated with solumedrol, antibiotics. CT and SLB arranged. Discharged home on prednisone, PPI and NAC 46 yo Male PMHx HTN T2DM Dyslipidemia GERD Renal cyst Periodic limb movement disorder B12 deficiency AVN of hip with hip replacement OSA Medications Diltiazem 180 mg daily Lovastatin 40 mg daily Metformin 1000 mg BID Omeprazole 20 mg daily Prednisone 10 mg daily NKDA 26

Environmental / Occupational History Down pillow No birds Regular humidifier use Mold on central air filters Worked as a manager and engineer for construction companies on dusty work sites 46 yo M Family Hx Father black lung Died at 41 2 paternal uncles, 1 aunt with ILD Died at 46, 46, and 51 Grandmother ILD Died 72 History of early graying in 30s Social Hx Life long non smoker No illicit drugs 7 alcohol units weekly 27

Physical exam BP 137/88, HR 117, RR 18, T 36.4, Sats 96% R/A No clubbing No crackles, wheeze No signs of pulmonary hypertension No signs of connective tissue disease Physiology Room air saturation was 94 % at rest. After 3 minutes of walking, oxygen saturation was 92 %. Date FVC FEV1 FEV1/FVC TLC DLCO March 3, 2014 2.43L (53%) 2.16L (58%) 89% 3.55L (54%) 14.4 (46%) May 11, 2011 3.10 L (60%) 2.63L (64%) 85% 28

Labs WBC 13, Hb 12.6, Plt 165 CPK normal ANA, RF, ANCA negative HP panel negative ACE normal 29

30

31

Surgical Lung Biopsy Left upper lobe surgical biopsy 3.6 x 1.6 x 0.7 cm 32

33

34

35

Case 3 Diagnosis Cellular and fibrosing nonspecific interstitial pneumonia with focal bronchiolocentric fibrosis and organizing pneumonia. Alveolar hemorrhage, likely procedurerelated. Connective tissue disease, HP, drug reaction, or familial ILD (known at time of dx). 36

Multidisciplinary Discussion Unclassifiable ILD Differential includes Chronic hypersensitivity pneumonitis (HP) Fibrotic nonspecific interstitial pneumonia (NSIP) With a familial predisposition 37

Case 3 Management Pulmonary rehab, Vaccines Mycophenolate (MMF) 1000 mg twice daily Wean prednisone once on full dose of MMF Continue PPI Weight loss Remove down and humidifier Serial PFTs Repeat serologies (Negative) Final Thoughts from the Panel 38